Misrepresentation of statin safety evidence

Lancet. 2014 Oct 4;384(9950):1263-4. doi: 10.1016/S0140-6736(14)61765-7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Evidence-Based Medicine / standards*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Professional Misconduct*
  • Randomized Controlled Trials as Topic

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors